- $4.17bn
- $4.35bn
- $1.08bn
Brief: Cactus Announces Fourth Quarter And Full Year 2022 Results
Cactus Inc expected to post earnings of 50cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tesla, Eton Pharma, Jack Henry & Associates
U.S. STOCKS ON THE MOVE-Levi Strauss, Salesforce, Eli Lilly
U.S. STOCKS ON THE MOVE-ProKidney Corp, Dentsply Sirona, Lipella Pharmaceuticals Inc
Cactus drops on pricing upsized stock offering
Cactus falls on $125 mln stock offering to fund acquisition
Brief: Cactus Announces Public Offering Of Common Stock
Brief: Cactus Announces Agreement To Acquire Flexsteel
U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris
U.S. STOCKS ON THE MOVE-Boeing, U.S. energy, Delek US
U.S. STOCKS ON THE MOVE-Kosmos Energy, Scisparc, Walgreens
Cactus gains after Q3 profit, revenue beat estimates
Cactus Inc reports results for the quarter ended in September - Earnings Summary
Brief: Cactus Announces Third Quarter 2022 Results
Cactus Inc expected to post earnings of 48cents a share - Earnings Preview
NYSE ORDER IMBALANCE 93440.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 62419.0 SHARES ON BUY SIDE
Brief: Cactus Announces Second Quarter 2022 Results